Key TakeawaysValue-based care in oncology emphasizes access, outcomes, and affordability, with patient empowerment and clinical trials being crucial components.CAR T-cell and bispecific therapies have revolutionized treatment, but financial toxicity and accessibility challenges persist.Pharmacists are integral in managing adverse events, ensuring treatment accessibility, and expediting insurance approvals.Collaborations and innovative care models are essential for balancing innovation […]
